Zymeworks Inc. Common Shares (ZYME): Price and Financial Metrics
Zymeworks Inc. Common Shares (ZYME)
Today's Latest Price: $39.12 USD
Updated Oct 30 7:00pm
Add ZYME to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
ZYME Stock Summary
- ZYME's price/sales ratio is 58.78; that's higher than the P/S ratio of 96.28% of US stocks.
- In terms of twelve month growth in earnings before interest and taxes, Zymeworks Inc is reporting a growth rate of 242.97%; that's higher than 94.23% of US stocks.
- Revenue growth over the past 12 months for Zymeworks Inc comes in at -40.21%, a number that bests just 6.29% of the US stocks we're tracking.
- If you're looking for stocks that are quantitatively similar to Zymeworks Inc, a group of peers worth examining would be CLLS, CUE, ARVN, APTX, and ACRS.
- ZYME's SEC filings can be seen here. And to visit Zymeworks Inc's official web site, go to www.zymeworks.com.
ZYME Stock Price Chart Interactive Chart >
ZYME Price/Volume Stats
| Current price | $39.12 | 52-week high | $52.75 |
| Prev. close | $39.98 | 52-week low | $20.33 |
| Day low | $38.30 | Volume | 250,715 |
| Day high | $40.31 | Avg. volume | 441,676 |
| 50-day MA | $40.15 | Dividend yield | N/A |
| 200-day MA | $37.55 | Market Cap | 1.78B |
Zymeworks Inc. Common Shares (ZYME) Company Bio
Zymeworks Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of bio-therapeutics for the treatment of cancer in Canada. The company was founded in 2003 and is based in Vancouver, BC.
Loading social stream, please wait...